Pharmaceutical

Next Presentation in Record-Breaking Sleep Apnea Webinar Series Announced

Live presentations by leading sleep researchers available globally to front-line clinicians MURFREESBORO, Tenn., July 30, 2024 /PRNewswire/ -- SleepWorld Magazine…

1 year ago

Labcorp Expands Collaboration with Ultima Genomics to Advance Whole Genome Sequencing Applications and Oncology Testing Capabilities

BURLINGTON, N.C., and FREMONT, Calif., July 29, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive…

1 year ago

RevHealth Announces First Pharma-Optimized AI Agency Platform

MORRISTOWN, N.J., July 30, 2024 /PRNewswire/ -- RevHealth, a full-service independent pharmaceutical marketing and communications agency, has announced the launch…

1 year ago

Prostate Cancer Foundation Canada Announces Leadership Transition

Dr. Abby C. Collier will take over from Leah Lariviere as Executive Director, effective August 1, 2024Vancouver, British Columbia--(Newsfile Corp.…

1 year ago

Phytanix Bio Publishes New Investor Deck Highlighting Strategic Vision and Growth Potential

NEW YORK and SANTA BARBARA, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- Phytanix Bio, a pioneering preclinical stage pharmaceutical company…

1 year ago

AGAPE ATP Corporation Strengthens Wellness Division via Innovative Incubation with Emerging Local SMEs

Expanding Elderly Care and Wellness Services with collaboration projects in the Pain Management Market and Elderly Care Solutions Market KUALA…

1 year ago

Envision Pharma Group Announces the Appointment of Bill Shirey to President of Life Science Commercialization

FAIRFIELD, CT / ACCESSWIRE / July 30, 2024 / Envision Pharma Group (Envision) announced today the appointment of Bill Shirey…

1 year ago

CNS Pharmaceuticals Expands Pipeline with In-License of Late Stage, Novel Potential Blood Brain Barrier Permeable Abeotaxane for Treatment of Brain Malignancies

Strategic in-license from Cortice Bioscience is highly synergistic with the ongoing potentially pivotal Berubicin program and demonstrates further commitment to…

1 year ago

Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences in August

NORWOOD, Mass., July 30, 2024 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today announced…

1 year ago

Evoke Pharma, Inc. Announces Reverse Stock Split

SOLANA BEACH, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily…

1 year ago